中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2012年
30期
60-62
,共3页
通心络胶囊%代谢综合症%高黏血症%血脂
通心絡膠囊%代謝綜閤癥%高黏血癥%血脂
통심락효낭%대사종합증%고점혈증%혈지
Tongxinluo Capsule%MS%hyperviscosity%Lipids
目的观察通心络胶囊对代谢综合症(metabolic syndrome,MS)患者血液流变学、血脂的影响.方法采用随机抽样方法选择我院经血液流变学化验确诊异常的MS患者164例,分为治疗组82例和对照组82例.两组均给予常规降压、调脂、降血糖、生活干预等治疗,治疗组加服通心络胶囊,12周为1疗程.结果两组患者血液流变学指标及血脂组内治疗前后比较,差异显著(P<0.05);治疗后两组间比较,差异显著(P<0.05).结论通心络胶囊对MS患者的血液流变学多项指标、血脂有影响,同时可改善患者的临床症状,未发现副作用.
目的觀察通心絡膠囊對代謝綜閤癥(metabolic syndrome,MS)患者血液流變學、血脂的影響.方法採用隨機抽樣方法選擇我院經血液流變學化驗確診異常的MS患者164例,分為治療組82例和對照組82例.兩組均給予常規降壓、調脂、降血糖、生活榦預等治療,治療組加服通心絡膠囊,12週為1療程.結果兩組患者血液流變學指標及血脂組內治療前後比較,差異顯著(P<0.05);治療後兩組間比較,差異顯著(P<0.05).結論通心絡膠囊對MS患者的血液流變學多項指標、血脂有影響,同時可改善患者的臨床癥狀,未髮現副作用.
목적관찰통심락효낭대대사종합증(metabolic syndrome,MS)환자혈액류변학、혈지적영향.방법채용수궤추양방법선택아원경혈액류변학화험학진이상적MS환자164례,분위치료조82례화대조조82례.량조균급여상규강압、조지、강혈당、생활간예등치료,치료조가복통심락효낭,12주위1료정.결과량조환자혈액류변학지표급혈지조내치료전후비교,차이현저(P<0.05);치료후량조간비교,차이현저(P<0.05).결론통심락효낭대MS환자적혈액류변학다항지표、혈지유영향,동시가개선환자적림상증상,미발현부작용.
Objective To observe the capsule pass in patients with MS on blood rheology、lipids. Methodshospital after tests confirmed abnormal blood rheology of the 164 cases of patients with MS, were randomly divided into treatment group and 82 cases in the control group of 82 cases. Both groups were given conventional blood pressure, lipid-lowering,hypoglycemic,such as the treatment of life-intervention, the administration conducted before and after their comparison between the two groups and compared the treatment group and then on the basis of the suit-capsule, A 12-week course of treatment for a statistical effect. Results Two sets ofhemorheology in patients withhyperlipidemia group before and after treatment, the difference was significant (P <0.05); after treatment between the two groups, the difference was significant (P <0.05). Conclusion Tongxinluo capsules of MS in patients with a number of indicatorshemorheology and lipids influential and can improve the patient's clinical symptoms, improve the quality of life, and without side effects.